GlaxoSmithKline (GSK), Shionogi & Co., Ltd. Say HIV Drug Beats Gilead Sciences, Inc. (GILD) Atripla in Test
7/11/2012 6:44:43 AM
More...
|
Shionogi & Co., Ltd. and Shionogi, Inc. Announce a Favorable Decision In FORTAMET® Preliminary Injunction Proceedings
12/7/2011 8:43:56 AM
More...
|
Shire plc Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi & Co., Ltd.
11/18/2011 10:38:15 AM
More...
|
MorphoSys AG and Shionogi & Co., Ltd. Agree Three-Year Extension of Research Partnership
11/2/2011 8:37:48 AM
More...
|
Evotec AG (EVTG.F) Achieves Two Milestones in Fragment-based Drug Discovery Alliance With Shionogi & Co., Ltd.
10/27/2011 10:16:12 AM
More...
|
Japan's Shionogi & Co., Ltd. to Acquire C&O Pharmaceutical Technology for About $182 Million
8/1/2011 8:05:28 AM
More...
|
Shionogi & Co., Ltd. Announces Commercial Availability of CUVPOSA(TM) (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions
4/7/2011 6:31:09 AM
More...
|
Graffinity Pharmaceuticals GmbH Enters into Drug Discovery Collaboration with Shionogi & Co., Ltd.
3/30/2011 9:22:32 AM
More...
|
Biocryst Pharmaceuticals (BCRX)'s Partner Shionogi & Co., Ltd. Receives Approval for Pediatric Use Of Flu Drug Peramivir in Japan
10/27/2010 8:23:35 AM
More...
|
Shionogi & Co., Ltd. Announces Reorganization of US Operations, New Leadership; New CEO Named
7/1/2010 11:28:36 AM
More...
|
|